Fig. 1
From: The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma
Kaplan–Meier analysis. (a) OS in the first-line group. (b) Progression-free survival in the first-line group. CI, confidence interval; OS, overall survival; PFS, progression-free survival.
